Olanzapine is an atypical antipsychotic medication classified as a thienobenzodiazepine. It is primarily used to treat schizophrenia and bipolar disorder by reducing psychotic symptoms such as hallucinations and manic episodes. The drug functions as a dopamine d2 receptor antagonist and also blocks several serotonin receptors including 5-ht2a and 5-ht2c. By modulating these neurotransmitter pathways it helps restore chemical balance in the brain and improves mood regulation and perception. Olanzapine also exhibits antihistamine activity that contributes to its sedative effect. The partial antagonism at noradrenergic and serotonergic receptors further enhances its antidepressant and anti-agitation properties. Overall the medication provides symptom control for psychotic and mood disorders through its combined receptor-blocking actions.

Olanzapine is an atypical antipsychotic medication used primarily to treat schizophrenia and certain mood disorders. It works by modulating dopamine and serotonin activity in the brain through antagonism at multiple receptor subtypes. Specifically it blocks d2 and d3 dopamine receptors as well as 5ht2a serotonin receptors which contributes to its antipsychotic effect. This receptor profile also allows Olanzapine to reduce psychotic symptoms such as hallucinations and delusions while improving mood stability. In addition its sedative properties stem from antagonism of h1 histamine receptors and its antiemetic action from 5ht3 receptor blockade. The combined effect of these actions leads to a reduction in positive symptoms of psychosis and helps maintain overall behavioral control. Olanzapine thus serves as a pharmacologic tool that influences neurotransmitter signaling to achieve therapeutic goals in clinical practice.

Olanzapine may cause drowsiness or sedation. It can increase weight gain and affect metabolism. Some people experience dizziness or lightheadedness when standing quickly. Changes in blood sugar levels have been reported in certain individuals. Elevated cholesterol and triglyceride levels are possible side effects. Rarely it may lead to involuntary muscle movements or tremor. Constipation or gastrointestinal discomfort can also occur. Occasionally it may affect sexual function or libido.

Olanzapine may cause drowsiness or sedation in some individuals. Weight gain can occur due to increased appetite. Elevated blood sugar levels have been reported in certain patients. Changes in cholesterol levels may be observed during treatment. Some people experience dizziness upon standing up. Tremors or muscle stiffness can affect movement. Rarely, low white blood cell count may be detected by blood tests.